<PubmedArticle>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">26246321</PMID>
<DateCompleted>
<Year>2015</Year>
<Month>12</Month>
<Day>01</Day>
</DateCompleted>
<DateRevised>
<Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1541-6100</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>145</Volume>
<Issue>9</Issue>
<PubDate>
<Year>2015</Year>
<Month>Sep</Month>
</PubDate>
</JournalIssue>
<Title>The Journal of nutrition</Title>
<ISOAbbreviation>J. Nutr.</ISOAbbreviation>
</Journal>
<ArticleTitle>Six and 12 Weeks of Caloric Restriction Increases β Cell Function and Lowers Fasting and Postprandial Glucose Concentrations in People with Type 2 Diabetes.</ArticleTitle>
<Pagination>
<MedlinePgn>2046-51</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3945/jn.115.210617</ELocationID>
<Abstract>
<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Caloric restriction alone has been shown to improve insulin action and fasting glucose metabolism; however, the mechanism by which this occurs remains uncertain.</AbstractText>
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We sought to quantify the effect of caloric restriction on β cell function and glucose metabolism in people with type 2 diabetes.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Nine subjects (2 men, 7 women) with type 2 diabetes [BMI (in kg/m(2)): 40.6 ± 1.4; age: 58 ± 3 y; glycated hemoglobin: 6.9% ± 0.2%] were studied using a triple-tracer mixed meal after withdrawal of oral diabetes therapy. The oral minimal model was used to measure β cell function. Caloric restriction limited subjects to a pureed diet (&lt;900 kcal/d) for the 12 wk of study. The studies were repeated after 6 and 12 wk of caloric restriction.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Fasting glucose concentrations decreased significantly from baseline after 6 wk of caloric restriction with no further reduction after a further 6 wk of caloric restriction (9.8 ± 1.3, 5.9 ± 0.2, and 6.2 ± 0.3 mmol/L at baseline and after 6 and 12 wk of caloric restriction, respectively; P = 0.01) because of decreased fasting endogenous glucose production (EGP: 20.4 ± 1.1, 16.2 ± 0.8, and 17.4 ± 1.1 μmol · kg(-1) · min(-1) at baseline and after 6 and 12 wk of caloric restriction, respectively; P = 0.03). These changes were accompanied by an improvement in β cell function measured by the disposition index (189 ± 51, 436 ± 68, and 449 ± 67 10(-14) dL · kg(-1) · min(-2) · pmol(-1) at baseline and after 6 and 12 wk of caloric restriction, respectively; P = 0.01).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Six weeks of caloric restriction lowers fasting glucose and EGP with accompanying improvements in β cell function in people with type 2 diabetes. An additional 6 wk of caloric restriction maintained the improvement in glucose metabolism. This trial was registered at clinicaltrials.gov as NCT01094054.</AbstractText>
<CopyrightInformation>© 2015 American Society for Nutrition.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Sathananthan</LastName>
<ForeName>Matheni</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Endocrinology, Diabetes &amp; Metabolism and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shah</LastName>
<ForeName>Meera</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Endocrinology, Diabetes &amp; Metabolism and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Edens</LastName>
<ForeName>Kim L</ForeName>
<Initials>KL</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Endocrinology, Diabetes &amp; Metabolism and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Grothe</LastName>
<ForeName>Karen B</ForeName>
<Initials>KB</Initials>
<AffiliationInfo>
<Affiliation>Department of Psychiatry &amp; Psychology, Mayo Clinic College of Medicine, Rochester, MN; and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Piccinini</LastName>
<ForeName>Francesca</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Information Engineering, University of Padua, Padua, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Farrugia</LastName>
<ForeName>Luca P</ForeName>
<Initials>LP</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Endocrinology, Diabetes &amp; Metabolism and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Micheletto</LastName>
<ForeName>Francesco</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Department of Information Engineering, University of Padua, Padua, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Man</LastName>
<ForeName>Chiara Dalla</ForeName>
<Initials>CD</Initials>
<AffiliationInfo>
<Affiliation>Department of Information Engineering, University of Padua, Padua, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cobelli</LastName>
<ForeName>Claudio</ForeName>
<Initials>C</Initials>
<AffiliationInfo>
<Affiliation>Department of Information Engineering, University of Padua, Padua, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rizza</LastName>
<ForeName>Robert A</ForeName>
<Initials>RA</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Endocrinology, Diabetes &amp; Metabolism and.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Camilleri</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Gastroenterology &amp; Hepatology.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vella</LastName>
<ForeName>Adrian</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>Divisions of Endocrinology, Diabetes &amp; Metabolism and vella.adrian@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y">
<DataBank>
<DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList>
<AccessionNumber>NCT01094054</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>R01 DK078646</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DK78646</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DK82396</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DKTR000135</GrantID>
<Agency>PHS HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D000068397">Clinical Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>J Nutr</MedlineTA>
<NlmUniqueID>0404243</NlmUniqueID>
<ISSNLinking>0022-3166</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D001786">Blood Glucose</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D002096">C-Peptide</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D006442">Glycated Hemoglobin A</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>9007-92-5</RegistryNumber>
<NameOfSubstance UI="D005934">Glucagon</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D001786">Blood Glucose</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D015992">Body Mass Index</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002096">C-Peptide</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D031204">Caloric Restriction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D003924">Diabetes Mellitus, Type 2</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000178">diet therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D002149">Energy Intake</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005215">Fasting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D005934">Glucagon</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006442">Glycated Hemoglobin A</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D007328">Insulin</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000097">blood</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D050417">Insulin-Secreting Cells</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="Y" UI="D019518">Postprandial Period</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D013997">Time Factors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">bariatric surgery</Keyword>
<Keyword MajorTopicYN="N">caloric restriction</Keyword>
<Keyword MajorTopicYN="N">disposition index</Keyword>
<Keyword MajorTopicYN="N">endogenous glucose production</Keyword>
<Keyword MajorTopicYN="N">gastric emptying</Keyword>
<Keyword MajorTopicYN="N">insulin action</Keyword>
<Keyword MajorTopicYN="N">insulin secretion</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>01</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>07</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>8</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26246321</ArticleId>
<ArticleId IdType="pii">jn.115.210617</ArticleId>
<ArticleId IdType="doi">10.3945/jn.115.210617</ArticleId>
<ArticleId IdType="pmc">PMC4548160</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Diabetes. 2013 Sep;62(9):3017-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23970521</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2009 Jan;32(1):14-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18931099</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2015 Feb;64(2):434-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25204975</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E1-E15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17341552</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2007 Feb 22;356(8):820-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17314341</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2009 Oct;58(10):2168-74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19794073</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 2010 Jul;33(7):1438-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20368410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Endocrinol (Oxf). 2010 Aug;73(2):189-96</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20039889</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obesity (Silver Spring). 2011 Nov;19(11):2149-57</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21593800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2012 Mar;95(3):609-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22318758</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2013 Sep;62(9):3027-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23610060</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2001 Jan;50(1):150-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11147781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Aliment Pharmacol Ther. 2002 Oct;16(10):1781-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12269971</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2004 Oct;287(4):E637-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15138152</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2004 Oct 13;292(14):1724-37</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15479938</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 1968 Jul;17(7):415-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4875169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 1985 Nov;61(5):917-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">4044780</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 1991 Jan;40(1):73-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2015976</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 1992 Mar;41(3):368-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1551497</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Biochem. 1993 Aug 1;212(2):526-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8214596</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 1993 Nov;77(5):1287-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8077323</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Care. 1998 May;21(5):687-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9589225</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obes Surg. 2005 Apr;15(4):474-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15946424</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2006 Dec;55(12):3536-49</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17130502</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Diabetes Endocrinol. 2014 Jan;2(1):38-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24579062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</PubmedArticle>